This is my latest post as part of a series reporting the available information on competing financial interests in ‘key opinion leaders’ in British psychiatry.
Professor Stephen Lawrie’s “Disclosure UK” declarations can be read here. Other sources of declarations for Professor Stephen Lawrie include, the Lancet, SIGN Guidelines and the Royal College of Psychiatrists.
The following is a recent sponsored educational meeting chaired by Professor Stephen Lawrie:
On the 17 August 2018 I received (again) invites to two promotional meetings “developed, organised and funded by Sunovion Pharmaceuticals Europe Ltd”. Professor Stephen Lawrie, The University of Edinburgh, is chairing both days:
I have written a number of times about the marketing of Latuda (Lurasidone) in the UK. These posts can be read here